The health effect of probiotics on high-fat diet-induced cognitive impairment, depression and anxiety: A cross-species systematic review

Neurosci Biobehav Rev. 2022 May:136:104634. doi: 10.1016/j.neubiorev.2022.104634. Epub 2022 Mar 23.

Abstract

Obesity is a complex disease with many co-morbidities, including impaired cognitive functions. Obese individuals often contain an aberrant microbiota. Via the microbiota-gut-brain axis, the altered microbiota composition can affect cognition or induce anxiety- or depressive-like behavior. Probiotics have been shown to alleviate both obesity- and neurobehavioral disorder-related symptoms. Here, we evaluated previously published results on the effectiveness of probiotic intervention in alleviating obesity- or high-fat diet (HFD)-related cognitive impairment, depression and anxiety. A systematic search was performed in PubMed, Embase, and Google Scholar until June 2021 to identify relevant articles. Seventeen studies were included: one human and sixteen animal studies. Overall, the findings support the beneficial health effect of probiotics on HFD-induced cognitive impairment and anxiety. However, the results suggest that multi-strain probiotic treatments should be used with caution, especially in the absence of HFD-induced impairment. Future studies should overcome the large variation in study design and high risk of bias found in the current evidence. Nevertheless, probiotic treatment, in particular using the Lactobacillus genus, seems promising.

Keywords: Anxiety; Cognition; Depression; Gut microbiota; High-fat diet; Learning and memory; Microbiota-gut-brain axis; Obesity; Probiotics.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Animals
  • Anxiety / therapy
  • Cognitive Dysfunction* / etiology
  • Depression / therapy
  • Diet, High-Fat / adverse effects
  • Humans
  • Obesity
  • Probiotics* / pharmacology
  • Probiotics* / therapeutic use